Cargando…

Correction to: Much ado about something: a response to “COVID-19: underpowered randomised trials, or no randomised trials?”

Detalles Bibliográficos
Autores principales: Haber, Noah A., Wieten, Sarah E., Smith, Emily R., Nunan, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8693129/
https://www.ncbi.nlm.nih.gov/pubmed/34937573
http://dx.doi.org/10.1186/s13063-021-05932-z
_version_ 1784619081157050368
author Haber, Noah A.
Wieten, Sarah E.
Smith, Emily R.
Nunan, David
author_facet Haber, Noah A.
Wieten, Sarah E.
Smith, Emily R.
Nunan, David
author_sort Haber, Noah A.
collection PubMed
description
format Online
Article
Text
id pubmed-8693129
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-86931292021-12-22 Correction to: Much ado about something: a response to “COVID-19: underpowered randomised trials, or no randomised trials?” Haber, Noah A. Wieten, Sarah E. Smith, Emily R. Nunan, David Trials Correction BioMed Central 2021-12-22 /pmc/articles/PMC8693129/ /pubmed/34937573 http://dx.doi.org/10.1186/s13063-021-05932-z Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Correction
Haber, Noah A.
Wieten, Sarah E.
Smith, Emily R.
Nunan, David
Correction to: Much ado about something: a response to “COVID-19: underpowered randomised trials, or no randomised trials?”
title Correction to: Much ado about something: a response to “COVID-19: underpowered randomised trials, or no randomised trials?”
title_full Correction to: Much ado about something: a response to “COVID-19: underpowered randomised trials, or no randomised trials?”
title_fullStr Correction to: Much ado about something: a response to “COVID-19: underpowered randomised trials, or no randomised trials?”
title_full_unstemmed Correction to: Much ado about something: a response to “COVID-19: underpowered randomised trials, or no randomised trials?”
title_short Correction to: Much ado about something: a response to “COVID-19: underpowered randomised trials, or no randomised trials?”
title_sort correction to: much ado about something: a response to “covid-19: underpowered randomised trials, or no randomised trials?”
topic Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8693129/
https://www.ncbi.nlm.nih.gov/pubmed/34937573
http://dx.doi.org/10.1186/s13063-021-05932-z
work_keys_str_mv AT habernoaha correctiontomuchadoaboutsomethingaresponsetocovid19underpoweredrandomisedtrialsornorandomisedtrials
AT wietensarahe correctiontomuchadoaboutsomethingaresponsetocovid19underpoweredrandomisedtrialsornorandomisedtrials
AT smithemilyr correctiontomuchadoaboutsomethingaresponsetocovid19underpoweredrandomisedtrialsornorandomisedtrials
AT nunandavid correctiontomuchadoaboutsomethingaresponsetocovid19underpoweredrandomisedtrialsornorandomisedtrials